Skip to main content
. 2016 Mar 25;60(4):2425–2434. doi: 10.1128/AAC.01667-15

TABLE 5.

Plasma biochemical analysis of female mice after 48 h of compound administration

Biochemical marker Compound Result after treatment with the following dose (mg/kg)a:
0b 12.5 25 50 100 200
ALT 35DAP073 57 ± 8 58 ± 0 51 ± 0 88 ± 51 77 ± 41 ND
35DAP081 56 ± 0.7 67 ± 13 82 ± 8 102 ± 23 116 ± 11
CK 35DAP073 935 ± 226 635 ± 80 368 ± 0 701 ± 260 870 ± 646 ND
35DAP081 503 ± 145 509 ± 145 737 ± 0 1,681 ± 310 1,162 ± 452
AST 35DAP073 183 ± 16 109 ± 0 113 ± 0 152 ± 37 242 ± 105 ND
35DAP081 105 ± 16 143 ± 21 285 ± 55 422 ± 132 376 ± 229
BUN 35DAP073 46 ± 11 51 ± 16 34 ± 0 43 ± 2 55 ± 12 ND
35DAP081 37 ± 7 29 ± 7 31 ± 10 29 ± 0 60 ± 29
a

Data are in milligrams per deciliter for blood urea nitrogen and units per liter for all other biochemical markers and are means ± SDs from two independent assays. Reference values (CECAL/Fiocruz) are as follows: blood urea nitrogen (BUN), up to 29 mg/dl; alanine aminotransferase (ALT), up to 132 U/liter; aspartate transaminase (AST), up to 247 U/liter; creatine kinase (CK), up to 1,070 U/liter. P was <0.05 by ANOVA for all samples. ND, not determined due to animal death at the higher dose.

b

Results are from one representative assay.